Latest Oncology Jobs

Director, Clinical Science – Oncology Clinical Development

Provides scientific leadership in oncology clinical development, contributing to study design, data interpretation, and regulatory deliverables within a defined clinical programme. Works closely with cross-functional teams and external experts to ensure scientific rigor and data integrity. Focuses on advancing cancer therapies with high unmet need through robust clinical science and collaboration.

GSK US$189,750 – US$316,250 pa

Hybrid Permanent

Director, Clinical Science – Oncology Clinical Development

Provides scientific leadership in oncology clinical development, contributing to study design, data interpretation, and regulatory documentation within a defined clinical programme. Works closely with cross-functional teams to ensure scientific rigor and alignment with clinical strategy, while supporting the execution of clinical studies from early to late stages. Focuses on generating robust clinical insights to advance cancer therapies with high unmet need.

GSK United States £189,750 – £316,250 pa

Hybrid Permanent

Director, HTA, Value & Evidence (HV&E), Obesity Early Pipeline

Lead the development and execution of global health economics and outcomes research (HEOR) strategies for Pfizer’s early-stage obesity and internal medicine pipeline. Design real-world evidence studies, economic models, and patient-reported outcomes frameworks to support market access and reimbursement. Collaborate with cross-functional teams and external stakeholders to generate data that demonstrates product value to payers and regulators.

Pfizer US$176,600 – US$294,300 pa

Head, Oncology Clinical Development - ADCs

Leads the end-to-end clinical development of an antibody-drug conjugate (ADC) oncology asset across multiple tumor types, from first-in-human through registrational trials and launch readiness. Responsible for shaping clinical strategy, overseeing global trials, engaging with regulatory authorities, and leading cross-functional teams in a matrixed environment. Involves governance leadership, scientific advisory boards, and integration of innovative approaches such as AI/ML and real-world evidence to accelerate development.

GSK US$242,250 – US$403,750 pa

Head, Oncology Clinical Development - ADCs

Leads the clinical development strategy for antibody-drug conjugates (ADCs) in oncology, spanning early- to late-phase trials across multiple tumor types. Responsible for end-to-end asset development, including regulatory approval and launch readiness, with a focus on scientific rigor, innovation in trial design, and cross-functional collaboration. Engages with global health authorities, governance bodies, and external experts to shape clinical and translational strategies.

GSK US$242,250 – US$403,750 pa

Head, Oncology Clinical Development - ADCs

Leads end-to-end clinical development of an antibody-drug conjugate (ADC) oncology asset across multiple tumor types, from first-in-human through registrational trials and market launch. Drives integrated clinical strategy, translational research, regulatory submissions, and cross-functional collaboration across global teams. Engages with governance bodies, scientific advisory boards, and external experts to shape development and competitive positioning.

GSK US$242,250 – US$403,750 pa

Medical Director, Oncology Clinical Development - Hematology

This role involves leading medical oversight and clinical development for oncology and hematology programs, with responsibilities spanning study design, safety monitoring, data interpretation, and regulatory engagement. The Medical Director will collaborate with cross-functional teams and external experts to ensure clinical integrity and patient-centered decision-making in late-stage drug development. The position requires deep expertise in hematology-oncology and experience in Phase I–III trials within a pharmaceutical or biotech setting.

GSK PLN 455,250 – PLN 758,750 pa

Medical Director, Oncology Clinical Development - Hematology

Serves as the physician lead within the oncology clinical development team, providing medical expertise to design, conduct, and interpret clinical studies in hematology oncology. Responsible for medical monitoring, safety oversight, protocol development, and cross-functional collaboration to ensure patient safety and clinical integrity. Engages with investigators and regulatory bodies, contributing to regulatory submissions and scientific communications.

GSK

Medical Director, Oncology Clinical Development - Hematology

This role involves providing medical leadership in oncology clinical development, with responsibilities spanning study design, medical monitoring, safety oversight, and data interpretation. The Medical Director will integrate physician-level insights into clinical trials, collaborate with cross-functional teams and external experts, and contribute to regulatory submissions and scientific communications. The position emphasizes patient-centered decision-making and real-world impact in cancer treatment innovation.

GSK £222,750 – £371,250 pa

Hybrid Permanent

Senior Director, Portfolio Integration Lead - Hematology

Leads cross-programme scientific strategy and integration across GSK’s oncology portfolio, with a focus on hematology. Provides expert guidance on disease biology, biomarker strategies, and clinical development innovation across multiple assets. Champions data-driven decision-making, trial innovation, and external engagement to align portfolio direction and accelerate development.

GSK Stevenage, United Kingdom US$242,250 – US$403,750 pa

Hybrid Permanent

Senior Director, Portfolio Integration Lead - Hematology

Leads scientific and strategic integration across GSK's hematology oncology portfolio, ensuring cross-program alignment and innovation in clinical development. Provides expert guidance on disease biology, biomarker strategies, and trial design while shaping portfolio-level decision-making. Operates as a senior individual contributor interfacing with clinical teams, external experts, and regulatory bodies.

GSK United States US$242,250 – US$403,750 pa

Hybrid Permanent

Senior Director, Portfolio Integration Lead - Hematology

Leads cross-programme scientific strategy and integration across GSK’s hematology oncology portfolio, ensuring alignment in clinical development, biomarker strategies, and innovative trial design. Acts as a senior scientific partner to Clinical Development Leads and drives data-driven decision-making using emerging technologies like AI. Operates at the portfolio level to shape disease-area strategy and support regulatory and governance engagement.

GSK US$242,250 – US$403,750 pa

Hybrid Permanent

Senior Director, Portfolio Integration Lead - Hematology

Lead scientific and strategic integration across GSK's hematology oncology portfolio, ensuring alignment of clinical development programmes, biomarker strategies, and innovative trial designs. Drive cross-asset coordination and decision-making at the disease level, leveraging deep oncology expertise and emerging technologies like AI. Engage with internal stakeholders and external experts to shape portfolio direction and regulatory strategy.

GSK US$242,250 – US$403,750 pa

Hybrid Permanent

Senior Director, Portfolio Integration Lead - Hematology

This role leads cross-programme scientific strategy and integration across GSK’s hematology oncology portfolio, ensuring alignment in disease biology, biomarker development, and clinical trial innovation. The individual will drive portfolio-level decision-making, shape clinical development approaches using emerging technologies like AI, and engage with external experts and regulatory bodies. It is a senior individual contributor position focused on strategic coherence across multiple assets rather than direct management of a single programme.

GSK US$242,250 – US$403,750 pa

Hybrid Permanent

Contract Manager

Manages end-to-end contract processes for Investigator Initiated Studies and Supported Collaborative Studies with academic and research institutions. Responsibilities include drafting, negotiating, and finalizing agreements, resolving contractual issues, ensuring timely execution, and supporting clinical development activities within a global biopharma environment.

GSK United Kingdom